Genus plc Receives “Buy” Rating from Liberum Capital (GNS)
Genus plc (LON:GNS)‘s stock had its “buy” rating reaffirmed by equities researchers at Liberum Capital in a research report issued on Tuesday. They currently have a GBX 1,400 ($23.17) price objective on the stock. Liberum Capital’s target price would indicate a potential upside of 23.78% from the stock’s previous close.
Genus plc (LON:GNS) traded up 0.88% during mid-day trading on Tuesday, hitting GBX 1141.00. 14,251 shares of the company’s stock traded hands. Genus plc has a 52 week low of GBX 924.50 and a 52 week high of GBX 1490.00. The stock has a 50-day moving average of GBX 1068.06 and a 200-day moving average of GBX 1076.43. The company’s market cap is £690.3 million.
Other equities research analysts have also recently issued reports about the stock. Analysts at Numis Securities Ltd initiated coverage on shares of Genus plc in a research note on Thursday, August 21st. They set an “add” rating and a GBX 1,290 ($21.35) price target on the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Genus plc in a research note on Friday, June 6th. They now have a GBX 1,000 ($16.55) price target on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. Genus plc has a consensus rating of “Hold” and an average price target of GBX 1,312.86 ($21.73).
Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with Analyst Ratings Network's FREE daily email newsletter.